CME Opportunities

 

 

 

Insights & Updates in Treatment and Prevention
of Clostridium difficile Infection: A CME Series

This series consists of five CME activities launching bi-monthly in 2017. As each activity becomes available, the links below will direct learners to the activities and content.

Clostridium difficile infection (CDI) is associated with significant morbidity and mortality. Further, recurrence of CDI is common after an initial episode. Although a number of therapies with varying mechanisms of action, are available to treat CDI and prevent recurrence, the management of CDI is complex and challenging. Clinicians require up-to-date knowledge of evidence-based treatment of initial and recurrent CDI to improve clinical outcomes.

This series is supported by an educational grant from Merck & Company and sponsored by the Academy for Continued Healthcare Learning and approved for AMA PRA Category 1 Credits.

Activity 1

Updates in the Treatment of C. difficile Infection: Faculty Insights

This CME activity addresses recent developments in the treatment and prevention of Clostridium difficile infection (CDI) and its recurrence. In these video-based interviews, two faculty discuss the clinical implications of recently released data on the management of CDI.

 

 

 

Activity 2

Recurrent C. difficile Infection: Expert Perspectives on Impacting Clinical Outcomes and Economics

This CME activity addresses the management of recurrent Clostridium difficile infection (CDI), including identification of at-risk patients, evidence-based treatment, and its economic impact. In this text-based interview, two faculty will discuss their approaches to the prevention and management of recurrent CDI.

 

 

 

Activity 3

Updates in the Treatment and Prevention of C. difficile: Hospital Perspectives

This CME activity addresses hospital perspectives on C. difficile infection such as surveillance, preventive strategies and tailoring therapy to disease severity and patient factors. In this video-based interview, two faculty will discuss their approaches to the prevention and management of CDI and recurrent CDI in the hospital setting.

 

 

 

Activity 4

Translating Recent Research into Clinical Decisions for C. difficile: Selection of Therapy

 In this text-based interview, Dr. Sahil Khanna will review recent published studies and data from national meetings that may impact selection of therapy for C. difficile and its recurrence. In addition to his own research, Dr. Khanna will review highlights from IDWeek 2017, ACG2017, and the International C. diff. Awareness Conference and Health EXPO.

 

 

 

Activity 5

Insights on the 2017 IDSA/SHEA Clinical Practice Guidelines for Clostridium difficile Infection in Adults: Focus on Recurrence 

In this text-based interview, Dr. Paul Feuerstadt reviews the updated 2017 IDSA/SHEA clinical practice guidelines for the treatment of C. difficile, with a focus on recurrent infection.